Global Orthobiologics Market is Anticipated to Grow at a CAGR of 4.44% During the Forecast Period (2021-26) | DelveInsight

New York, USA, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Global Orthobiologics Market is Anticipated to Grow at a CAGR of 4.44% During the Forecast Period (2021-26) | DelveInsight

As per DelveInsight analysis, a growing geriatric population at risk of developing various bone degenerative disorders, an increase in traumatic injuries such as car accidents, sports injuries, and others are expected to boost the Orthobiologics market growth. Furthermore rising investments in R&D and collaborations by key manufacturers, as well as an increase in various orthobiologic product approvals will also drive the market.

DelveInsight's Orthobiologics Market Insights and Forecast report provides the current and forecast Orthobiologics market, upcoming developments in the medical devices, individual market shares, challenges, drivers, barriers, market growth trends, and key players in the Orthobiologics market.

Some of the Key Highlights from the Orthobiologics Market Report

• According to DelveInsight analysis, North America is expected to dominate the overall Orthobiologics Market during the forecasted period.
• The leading Orthobiologics companies working diligently in the market include Medtronic, Stryker, Collagen Matrix, Inc., Arthrex, Inc., Bioventus, Sanofi, Seikagaku Corporation, DePuy Synthes (Johnson & Johnson), Globus Medical, Zimmer Biomet, NuVasive Inc., SeaSpine, Baxter, Exactech, Inc., RTI Surgical, Biomatlante, Fidia Farmaceutici S.p.A, LG Chem, TERUMO BCT, INC., Anika Therapeutics, Inc., Orthofix Medical Inc., Kuros Biosciences, XTANT MEDICAL, APTISSEN, BONESUPPORT AB, and others.
• As per DelveInsight estimates, the Global Orthobiologics Market size was valued at USD 5.33 billion in 2020 and is expected to grow at a CAGR of 4.44% from 2021 to 2026, reaching USD 6.84 billion by 2026.
• On July 28, 2021, Orthofix Medical Inc., launched fiberFUSE strip, an advanced demineralized fiber bone graft solution containing cancellous bone in the US.
• On July 13, 2021, RTI Surgical entered into a long-term strategic agreement with Exatech for the development and supply of biologic bone substitutes. As part of the agreement, RTI Surgical acquired Exactech's Optecure®, a 510(k)- cleared demineralized bone matrix for use as a bone graft extender in the spine, pelvis, and extremities.
• On August 24, 2020, Xtant Medical Holdings, Inc. launched its Matriform® Si, a silicated synthetic bone graft strip designed and cleared for spinal fusion procedures in the US.

To pick on the latest highlights, get the snapshot of the key highlights entailed in the Orthobiologics Detailed report.

Orthobiologics Overview

Orthobiologics are substances used by orthopedic surgeons to aid in the healing of injuries. They aid in the healing of broken bones as well as injured muscles, tendons, and ligaments. These products are frequently made from substances found naturally in your body.

Orthobiologics therapy or Orthobiologic medicine  is a cutting-edge field of Regenerative Medicine that employs the body's own cells and healing factors to potentially reverse the debilitating effects of osteoarthritis and accelerate healing of tendon and/or ligament injuries (rotator cuff tendonitis, ankle sprain, etc). Furthermore, the field of interventional orthobiologics is transforming orthopedic medicine.

To learn more get a snapshot of Orthobiologic Therapy

Orthobiologics Market Insights

Geographically, the Orthobiologics market is being studied for North America, Europe, Asia-Pacific, and the Rest of the World. However, North America is expected to dominate the global market. This dominance is due to an increase in traumatic injuries caused by falls, accidents, and other causes in the region. Furthermore, rising geriatric and obese populations in the region, rising incidences of spinal disorders, and rising physician and patient awareness of newly introduced orthobiologic treatment procedures and technologies are contributing to the region's Orthobiologic market growth.

Furthermore, the presence of key Orthobiologics market players such as Arthrex Inc., Stryker Corporation, and Medtronic, among others, as well as their strategic business activities for the development of new orthobiologics for the treatment of various bone-related disorders, will propel the regional Orthobiologics market. For instance, Bioventus entered into a development collaboration agreement with MTF Biologics in June 2019 to co-develop the next generation placental tissue product for the treatment of painful musculoskeletal conditions, with an initial focus on knee osteoarthritis.

Learn more about the market landscape @ Orthobiologics Market Assessment
Orthobiologics Market Dynamics

The Orthobiologics market is currently expanding at a faster rate due to the growing burden of the geriatric population, which is more susceptible to developing bone degenerative disorders such as osteoarthritis, degenerative disc disorders, and others. Furthermore, the recent approval and product launches are expected to fuel the Orthobiologic market. 

However, high orthobiologics treatment costs and stringent regulatory approval processes are likely to stymie the orthobiologics market. The Orthobiologics market grew slowly as a result of the COVID-19 pandemic. This is because the number of elective procedures was postponed during the pandemic. Furthermore, the temporary closure of clinics due to the nationwide lockdown, disruption in supply due to logistical restrictions imposed during the COVID-19 wave, and hospitals shifting their focus to COVID management all had an impact on orthobiologics demand.

Get a sneak peek at the Orthobiologics market drivers & barriers @ Orthobiologics Market Dynamics Analysis

Scope of the Urinary Incontinence Devices Market Report

• Coverage: Global
• Study Period: 2021-2026
• Market Segmentation By Type - Viscosupplementation Products, Demineralized Bone Matrices, Bone Morphogenic Protein, Synthetic Bone Substitutes, Bone Grafts, and Others
• Market Segmentation By Application - Osteoarthritis, Spinal Fusion, Reconstructive & Fracture Recovery, Soft-Tissue Injuries, Maxillofacial and Dental Applications
• Market Segmentation By End-User- Hospitals, Orthopaedic Clinics, and Others
• Market Segmentation By Geography - North America, Europe, Asia-Pacific, and Rest of World
• Key Orthobiologics Companies - Medtronic, Stryker, Collagen Matrix, Inc., Arthrex, Inc., Bioventus, Sanofi, Seikagaku Corporation, DePuy Synthes (Johnson & Johnson), Globus Medical, Zimmer Biomet, NuVasive Inc., SeaSpine, Baxter, Exactech, Inc., RTI Surgical, Biomatlante, Fidia Farmaceutici S.p.A, LG Chem, TERUMO BCT, INC., Anika Therapeutics, Inc., Orthofix Medical Inc., Kuros Biosciences, XTANT MEDICAL, APTISSEN, BONESUPPORT AB,  and others.
• Porter's Five Forces Analysis
• Product Profiles
• Case Studies 
• KOL's Views
• Analyst's View

Delveinsight Analysis: The Orthobiologics market is expected to grow at a CAGR of 4.44% and will reach USD 6.84 billion by 2026.

Know more about which MedTech player is set to emerge as the trendsetter @ Orthobiologics Companies

Table of Contents 

Learn more about the devices market layout @ Orthobiologics Regulatory and Patent Analysis

Related Reports

Orthotic Devices Market

Orthotic Devices Market Insight, Competitive Landscape, and Market Forecast, 2026 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Orthotic Devices companies involved, such as Ottobock, Boston Orthotics & Prosthetics, LeTourneau Prosthetics, and Orthotics, B BOUNDLESS BIOMECHANICAL BRACING INC., Becker Orthopedic, among others.
Spine Augmentation Systems Market
Spine Augmentation Systems Market Insight, Competitive Landscape, and Market Forecast, 2026 report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key Spine Augmentation Systems companies involved, such as Alphatec Holdings, Inc., B. Braun Melsungen AG, Exactech, Inc., Globus Medical, Inc., among others.
Spinal Osteosynthesis Units Market
Spinal Osteosynthesis Units Market Insight, Competitive Landscape, and Market Forecast, 2026 report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key Spinal Osteosynthesis Units companies involved, such as Stryker, Zimmer Biomet, Integra LifeSciences, B. Braun, Johnson & Johnson, Orthofix, among others.
Spinal Stenosis Devices Market
Spinal Stenosis Devices Market Insight, Competitive Landscape, and Market Forecast, 2026 report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key Spinal Stenosis Devices companies involved, such as Boston Scientific Corporation, Stryker, Medtronic, Sintea Biotech, Surgalign, Spinal Simplicity LLC, among others.
Spinal Cord Stimulators (SCS) Market
Spinal Cord Stimulators (SCS) Market Insight, Competitive Landscape, and Market Forecast, 2026 report delivers an in-depth understanding covering the market trends, market drivers, market barriers, and key Spinal Cord Stimulators companies involved, such as Boston, Scientific and corporation, Medtronic plc, Nevro corp., St. Jude Medical, Greatbatch and Stimwave, among others.
Spinal Decompression/Traction Devices Market
Spinal Decompression/Traction Devices Market Insight, Competitive Landscape, and Market Forecast, 2026 report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key Spinal Decompression companies involved, such as DJO LLC (Colfax Corporation), BTL, Vax-D Medical Technologies, CERT Health Sciences, LLC, Spinal Designs International, Inc., among others.
Spinal Implants Market
Spinal Implants Market Insight, Competitive Landscape, and Market Forecast, 2026' report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key Spinal Implants companies involved, such as Medtronic, Johnson & Johnson, Zimmer Biomet, Stryker Corporation, B. Braun Melsungen AG, NuVasive®, Inc., Orthofix Medical Inc., among others. 

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.  Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Get in touch with our team to get more detailed insights on how the MedTech Market is expected to evolve in the coming years and to formulate innovative business solutions, at Healthcare Due Diligence Services

For more insights, visit Pharma, Healthcare, and Biotech News 

Contact Us

Shruti Thakur 

info@delveinsight.com 

+1(919)321-6187 

www.delveinsight.com